Cargando…
P1152: RESULTS FROM A PHASE I PHARMACOKINETIC (PK) AND SAFETY STUDY OF TRPH-222, A NOVEL CD22-TARGETING ANTIBODY-DRUG CONJUGATE, IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON-HODGKIN LYMPHOMA (R/R NHL)
Autores principales: | Hernandez-Ilizaliturri, F. J., Kuruvilla, J., Christian, B. A., Flinn, I. W., Assouline, S. E., Ulrickson, M. L., Landsburg, D. J., Stuart, M., Lowman, H., Levin, N., Maetzel, D., Viller, N. N., MacLaren, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430507/ http://dx.doi.org/10.1097/01.HS9.0000847476.69621.cd |
Ejemplares similares
-
Conformer‐selective Photodynamics of TrpH(+)−H(2)O
por: Molina, Franco, et al.
Publicado: (2022) -
Biomarkers in NHL
por: Malek, Sami N.
Publicado: (2011) -
A 1152 channel timing system for an electromagnetic calorimeter readout
por: Bonesini, M, et al.
Publicado: (1987) -
1152. Microbiology of Pediatric Neck Infections Based on Age and Anatomic Location
por: Dimo, Joana, et al.
Publicado: (2021) -
PB2333: CAR-T CELL THERAPY IS A EXCELLENT STRATEGY FOR R/R B-NHL
por: Rui, Liu, et al.
Publicado: (2023)